TP53 and glioma: Thus, we propose the following model: in salinomycin-treated glioma cells, ROS production triggers p53-Cyp-D mitochondrial association to open mPTP, leading to secondary ROS production/accumulation in mitochondria and release from mitochondrial to cytosol, causing further oxidative damages, and cell necrosis (Fig. 5h).